Investor Alert

New York Markets After Hours

April 18, 2021, 11:55 p.m. EDT

Global Human Insulin Market to be Driven by rising health awareness among increasing diabetic population across the globe in the Forecast Period of 2021-2026

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Apr 18, 2021 (SUPER MARKET RESEARCH via COMTEX) -- The new report by Expert Market Research titled, 'Global Human Insulin Market Report and Forecast 2021-2026', gives an in-depth analysis of the human insulin market, assessing the market based on its segments like product type, type, brand, delivery service, applications and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter's Five Forces models.

Note 1: For a snapshot of the primary and secondary data of the market (2015-2025), along with business strategies and detailed market segmentation, please click on the request sample report. The sample report shall be delivered to you within 24 hours.

Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/human-insulin-market/requestsample

The key highlights of the report include:

Market Overview (2016-2026)

  • Historical Market Size (2020): USD 36 billion

  • Forecast CAGR (2021-2026): 4.7 %

  • Forecast Market Size (2026): USD 48 billion

Factors such as rising population with diabetes, increasing population sensitivity to main risk drivers, growing consumer demand for analogues with human insulin, technical developments in human insulin-supply networks and advantageous medical reimbursement can be attributed to market growth. However, the market's growth is being stifled by tight regulatory criteria for product clearance. Furthermore, high commodity production costs are presenting major demand growth challenges.

Industry Definition and Major Segments

Human insulin is a synthetic insulin developed in labs using e. coli bacteria to raise insulin protein levels. Human insulin can be taken orally or supplied through insulin infusion pumps. Syringes, injection needles, and insulin pumps are examples of common insulin infusion systems. These instruments are used to ensure that insulin is administered on time and on budget.

Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/human-insulin-market

Based on product type, the market is divided into:

  • Drugs

  • Delivery Device

Based on type, the industry can be segmented into:

  • Insulin Analogs and Biosimilars

  • Delivery Device

Insulin analogs and biosimilars is further divided on the basis of types into long acting, rapid acting, and pre-mixed, whereas delivery device is divided into intermediate-acting, short-acting, pre-mixed.

By brand, the industry is categorised into:

  • NovoRapid/Novolog

  • Humalog

  • Insuman

  • Humulin

  • Lantus

  • Actrapid, Insulatard, and Mixtard

  • Others

Based on delivery service, the industry is segregated into:

  • Pens

  • Syringes

  • Pen Needles

  • Others

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.